RMD
Price
$270.16
Change
+$2.85 (+1.07%)
Updated
Sep 26, 04:46 PM (EDT)
Capitalization
39.14B
27 days until earnings call
SOLV
Price
$71.59
Change
+$1.13 (+1.60%)
Updated
Sep 26, 01:28 PM (EDT)
Capitalization
12.22B
41 days until earnings call
Interact to see
Advertisement

RMD vs SOLV

Header iconRMD vs SOLV Comparison
Open Charts RMD vs SOLVBanner chart's image
ResMed
Price$270.16
Change+$2.85 (+1.07%)
Volume$400
Capitalization39.14B
Solventum
Price$71.59
Change+$1.13 (+1.60%)
Volume$100
Capitalization12.22B
RMD vs SOLV Comparison Chart in %
Loading...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RMD vs. SOLV commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a Buy and SOLV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (RMD: $267.31 vs. SOLV: $70.46)
Brand notoriety: RMD and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RMD: 84% vs. SOLV: 114%
Market capitalization -- RMD: $39.14B vs. SOLV: $12.22B
RMD [@Pharmaceuticals: Other] is valued at $39.14B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $12.22B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 0 FA rating(s) are green whileSOLV’s FA Score has 0 green FA rating(s).

  • RMD’s FA Score: 0 green, 5 red.
  • SOLV’s FA Score: 0 green, 5 red.
According to our system of comparison, both RMD and SOLV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 4 TA indicator(s) are bullish while SOLV’s TA Score has 5 bullish TA indicator(s).

  • RMD’s TA Score: 4 bullish, 5 bearish.
  • SOLV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than RMD.

Price Growth

RMD (@Pharmaceuticals: Other) experienced а -2.19% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -5.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.21%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.58%.

Reported Earning Dates

RMD is expected to report earnings on Oct 23, 2025.

SOLV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($39.1B) has a higher market cap than SOLV($12.2B). SOLV has higher P/E ratio than RMD: SOLV (32.32) vs RMD (28.11). RMD YTD gains are higher at: 17.649 vs. SOLV (6.661). RMD has higher annual earnings (EBITDA): 1.92B vs. SOLV (1.28B). RMD has more cash in the bank: 1.21B vs. SOLV (492M). RMD has less debt than SOLV: RMD (852M) vs SOLV (7.82B). SOLV has higher revenues than RMD: SOLV (8.39B) vs RMD (5.15B).
RMDSOLVRMD / SOLV
Capitalization39.1B12.2B320%
EBITDA1.92B1.28B151%
Gain YTD17.6496.661265%
P/E Ratio28.1132.3287%
Revenue5.15B8.39B61%
Total Cash1.21B492M246%
Total Debt852M7.82B11%
FUNDAMENTALS RATINGS
RMD: Fundamental Ratings
RMD
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
37
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RMDSOLV
RSI
ODDS (%)
Bearish Trend 2 days ago
49%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 19 days ago
64%
Declines
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMUB49.87-0.09
-0.18%
iShares Long-Term National Muni Bd ETF
VCEB63.95-0.15
-0.23%
Vanguard ESG US Corporate Bond ETF
BFEB46.88-0.12
-0.25%
Innovator U.S. Equity Buffer ETF™ - Feb
FTXR34.60-0.37
-1.05%
First Trust Nasdaq Transportation ETF
IEUS66.05-0.90
-1.34%
iShares MSCI Europe Small-Cap ETF

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
-1.89%
NVST - SOLV
53%
Loosely correlated
-2.73%
BAX - SOLV
50%
Loosely correlated
-3.77%
RMD - SOLV
48%
Loosely correlated
-2.51%
AZTA - SOLV
48%
Loosely correlated
-3.56%
ALC - SOLV
46%
Loosely correlated
-2.35%
More